Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Sign up for our Annual "Lung Cancer Highlights" Program with Dr. Natasha Leighl!
Author
Howard (Jack) West, MD

We'll kick off our monthly live webinar series, co-sponsored by GRACE along with LUNGevity Foundation, with our annual "Highlights in Lung Cancer" program. This one, featuring the leading developments from 2012, will be by Dr. Natasha Leighl, medical oncologist and lung cancer expert at Princess Margaret Hospital, as well as Assistant Professor of Medicine at the University of Toronto in Ontario, Canada. Dr. Leighl has been an internationally recognized leader in thoracic oncology and also a friend of mine for more than a decade. She's also been a friend and fan of GRACE, but we haven't reached out to her enough, so it's only fitting that we rectify that by having her provide her wonderful perspective for our Lung Cancer Highlights program.

This program will be on January 17th at 7 PM Eastern, 4 PM Pacific time, when Dr. Leighl will cover topics ranging from immunotherapy to new targets and potential targeted therapies, as well as newly identified mechanisms of acquired resistance and potential strategies for addressing this.

We'll turn her presentation into a series f free podcasts to be released on the GRACE and LUNGevity websites, but you can learn the key points first and even ask your own live questions after her live presentation. So please join us on January 17th! As always, it's free, and you can sign up through this link.

Next Previous link

Previous PostNext Post

Related Content

Image
Videoteca de Cáncer de Pulmon - 2025
Video
Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente en cáncer de pulmón. El Dr. Raez aborda la terapia para cánceres de pulmón EGFR y ALK, además de analizar otros tres temas de actualidad. La Dra. Viola y la Dra. Riaño también contribuyen a esta videoteca, cada una presentando tres temas relevantes sobre el cáncer de pulmón.
Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
Image
Rare cancers
Video
In these videos,  Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment.  To watch the complete playlist, click here.  

Forum Discussions

Can SCLC also be treated with targeted therapy?

Hi amitchouhan,

Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...

Recent Comments

JOIN THE CONVERSATION
Thanks for sharing—amazing…
By MakaylaLove on
Hi Hopish hope,  Welcome to…
By JanineT GRACE … on
Yes, it's crucial to discuss…
By JanineT GRACE … on